Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,548.00
Ask: 12,550.00
Change: 6.00 (0.05%)
Spread: 2.00 (0.016%)
Open: 12,570.00
High: 12,704.00
Low: 12,472.00
Prev. Close: 12,550.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-UK steps vaccinations as COVID surges, worst weeks still to come

Mon, 11th Jan 2021 07:42

(Adds more quotes)

By Michael Holden

LONDON, Jan 11 (Reuters) - Britain is facing the worst weeks
of the COVID-19 pandemic, its chief medical officer said on
Monday, with the health service facing a "dangerous time" as
deaths and cases hit record highs before the rollout of a mass
vaccination programme.

Deaths from the virus have now exceeded 81,000 in the United
Kingdom - the world's fifth-highest toll - with more than 3
million people testing positive. A new, more transmissible
variant of the disease is surging through the population, with
one in 20 people in parts of London now infected.

In a bid to get on top of the pandemic and to try to restore
some degree of normality by the spring, Britain is rushing out
its largest ever vaccination programme, with shots to be offered
to all those in its top four priority categories - about 15
million people - by the middle of next month.

But the government's chief medical adviser Chris Whitty
warned the situation would deteriorate in the meantime.

"The next few weeks are going to be the worst weeks of this
pandemic in terms of numbers into the NHS (National Health
Service)," he said.

"Anybody who is not shocked by the number of people in
hospital who are seriously ill at the moment and who are dying
over the course of this pandemic, I think, has not understood
this at all. This is an appalling situation," he told BBC TV.

"SIGNIFICANT CRISIS"

During the peak of the first outbreak in April, about 18,000
people were in hospital but now there are 30,000, Whitty said,
adding the health service was facing "a significant crisis".

"Everybody says that this is the most dangerous time we've
really had in terms of numbers into the NHS," he said.

On Friday, London's mayor said the British capital's
hospitals were in danger of being overwhelmed by COVID patients,
and ministers and health chiefs have pleaded with people to
respect lockdown measures and stay at home unless it was
essential to go out.

The government is pinning its hopes on a mass vaccination
programme to offer a way out of the pandemic by the spring.

Britain was the first country to approve vaccines developed
by Oxford-AstraZeneca and by Pfizer/BioNTech
, and on Friday approved Moderna's shot. It
is aiming to offer shots to 15 million people by the middle of
next month.

To reach that target, which will require delivering 2
million vaccines a week, the government is opening seven big
vaccination centres while additional doctors' surgeries,
hospitals and some pharmacies will also start delivering shots.

"The vaccinations are really beginning to ramp up, 200,000 a
day, we've done an incredible job this past week," Nadhim
Zahawi, the minister in charge of the vaccination programme,
told Sky News

Those in the four highest risk levels, including those over
70, the most clinically vulnerable and frontline health workers,
will be offered the vaccines by February 15, he said.

"We are now very close to the point, with the vaccinations,
where we are able to get on top of this, but it is not yet,"
Whitty said.

There have been calls for the government to take tougher
action against those who break the lockdown rules, but Zahawi
said ministers did not want to "go any tougher" although
existing measures might be more tightly enforced.

"These rules are not boundaries to be pushed against," he
said. "What we need is people to behave as if they've got the
virus and so that we can bring this virus under control whilst
we vaccinate."
(Additional reporting by Kate Holton, William Schomberg and
James Davey; writing by Michael Holden; editing by Estelle
Shirbon, Guy Faulconbridge and Angus MacSwan)

More News
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.